Improving mitochondrial phenotypes with pharmaceuticals

Published on July 31, 2024   19 min

A selection of talks on Cell Biology

Please wait while the transcript is being prepared...
0:00
My name is Christopher Perry. I am an Associate Professor in the School of Kinesiology and Health Science and director of the Muscle Health Research Center at York University in Toronto, Canada. This lecture will provide an introduction to the principles of mitochondrial-targeted pharmaceuticals.
0:20
The lecture will first provide an overview of various mitochondrial functions as well as an example of how mitochondrial-derived signals can serve as a means of communication throughout the cell. Following this, mitochondrial responses to stress signals will be described. With this foundational knowledge, an overview of mitochondrial therapeutics will be provided with specific examples of preclinical and clinical research in various disease states.
0:48
Many cellular processes are powered by energy that is shuttled by the adenylate known as ATP or adenosine triphosphate. ATP-utilizing proteins hydrolyze ATP into ADP, or adenosine diphosphate, by removing a phosphate. Mitochondria synthesize ATP by rephosphorylating this ADP through a process known as oxidative phosphorylation given oxygen is required for this process. Briefly, nutrients derived from our food or stored in cells throughout our bodies are catabolized through specific enzymatic pathways. This process transfers electrons from nutrients such as glucose, fatty acids, and amino acids to electron carriers or reducing equivalents known as NADH and FADH2. Those terms are correct once they have received the electrons. Electrons are transferred from these reducing equivalents to specific protein complexes in the mitochondrial electron transport chain also known as the electron transport system. Electrons flow from one component to the next throughout the system by following a path of increasing redox potentials whereby each component has a greater potential to accept an electron than the previous component. Oxygen is the final electron acceptor as you will see on the right by Complex IV. As electrons flow through this system, protons are pumped from the matrix to the intermembrane space through Complexes I, III, and IV. The accumulation of protons generates a charge differential relative to the matrix thereby creating the proton motive force. This differential drives the re-entry of protons into the matrix through ATP synthase thereby powering the phosphorylation of ADP into ATP. Electron transfer to oxygen at Complex IV produces water.

Quiz available with full talk access. Request Free Trial or Login.

Hide

Improving mitochondrial phenotypes with pharmaceuticals

Embed in course/own notes